Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combination Therapy for the Treatment of Obstructive Sleep Apnea

Trial Profile

Combination Therapy for the Treatment of Obstructive Sleep Apnea

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 29 Jan 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Dec 2014.
    • 22 May 2013 Preliminary results for 5 patients presented at the 109th International Conference of the American Thoracic Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top